论文部分内容阅读
异名 AK-124,Hapase,Plasvata) 药效分类血栓溶解药开发单位 (日)Asahi/Kowa 上市厂商 (日)Kowa Co Ltd(Hapase);Asahi(Plasvata)1991年上市。本品为含有527个氨基酸残基(C_(2569)H_(389)N_(746)O_(781)S_(40);分子量59007.95)的糖朊,由人肺双倍成纤维细胞产生。药理 Tisokinase是一种血栓溶解药。内含人正常细胞经细胞培养而产生的组织血纤维蛋白溶酶原激活剂(t-PA)。本品溶解血
Synonyms AK-124, Hapase, Plasvata) Pharmacodynamic class Thrombolytic drug development unit (day) Asahi / Kowa Listed manufacturer Kowa Co Ltd (Hapase); Asahi (Plasvata) Listed in 1991. The product is a glycoprotein containing 527 amino acid residues (C_ (2569) H_ (389) N_ (746) O_ (781) S_ (40); molecular weight 59007.95) produced by human lung double fibroblasts. Pharmacology Tisokinase is a thrombolytic drug. Contains tissue plasminogen activator (t-PA) produced by cell culture of normal human cells. This product dissolves blood